M35.89, Other specified systemic involvement of connective tissueICD-10-CM
No Prior Auth Required
No active coverage policies found for this code (low confidence)
CGS-J15-L38920, Off-label Use of Rituximab and Rituximab Biosimilars
J15
CGS-J18-L38920, Off-label Use of Rituximab and Rituximab Biosimilars
J18
A57554, Billing and Coding: Immune Globulins
J5
A57478, Billing and Coding: Nerve Conduction Studies and Electromyography
J5
Ask Backwork about documentation requirements, denial risks, or coverage in your state.
J5
WPS-J5-L34771, Immune Globulins
J5
A59434, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J5
A58893, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J6
A57668, Billing and Coding: Nerve Conduction Studies and Electromyography
J6
NGS-J6-L35098, Nerve Conduction Studies and Electromyography
J6
WPS-J8-L34594, Nerve Conduction Studies and Electromyography
J8
WPS-J8-L34771, Immune Globulins
J8
A57657, Billing and Coding: Sedimentation Rate, Erythrocyte
J9
FIRST_COAST-L34021, Sedimentation Rate, Erythrocyte
J9
A59764, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
J9
NGS-JK-L35098, Nerve Conduction Studies and Electromyography
JK
A59766, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
JL
A58582, Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars
A58865, Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
A56619, Billing and Coding: Nerve Conduction Studies and Electromyography